Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 7 of 39

  1. Bupivacaine Liposome Injection

    Jian Li

    Local Analgesia Via Infiltration

    approved small molecule active

    1 trial

  2. Bupivacaine SNB

    Pacira Ireland Limited

    Pain

    approved small molecule completed

    1 trial

  3. Bupivacaine liposome injectable suspension

    Heron Therapeutics

    Analgesia

    approved small molecule completed

    1 trial

  4. Bupivacaine liposome injectable suspension (IPSA block)

    Pacira Ireland Limited

    Total Knee Arthroplasty

    approved small molecule active

    1 trial

  5. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    approved small molecule completed

    28 trials

  6. Buprenorphine (Subutex)

    Indivior Pty Ltd

    Opioid Dependency

    approved small molecule completed

    1 trial

  7. Buprenorphine + naloxone (Suboxone)

    Indivior Pty Ltd

    Opiate Dependence

    approved small molecule completed

    1 trial

  8. Buprenorphine Extended-Release Injection

    Indivior Pty Ltd

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  9. Buprenorphine transdermal patch

    Mundipharma Pty Limited

    Osteoarthritis

    approved small molecule completed

    1 trial

  10. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  11. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    2 trials

  12. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

  13. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    approved small molecule completed

    2 trials

  14. Bupropion Extended Release Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Postpartum Smoking Relapse

    approved small molecule active

    1 trial

  15. Bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    2 trials

  16. Buspirone

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  17. Busulfan

    The First People's Hospital of Lianyungang

    Thalassemia Major

    approved small molecule completed

    1 trial

  18. Butylphthalide

    The First People's Hospital of Lianyungang

    Focal Epilepsy

    approved small molecule active

    1 trial

  19. Byfavo

    Hospital Authority, Hong Kong

    Bronchoscopy

    approved small molecule completed

    1 trial

  20. C1 inhibitor (human) [C1 INH]

    Takeda

    Hereditary Angioedema

    approved mab completed

    1 trial

  21. C4221026

    Pfizer Australia Pty Ltd

    Solid tumors

    approved small molecule active

    1 trial

  22. C4951004/BHV3000-406

    Pfizer Australia Pty Ltd

    Migraine attacks with or without aura

    approved small molecule active

    1 trial

  23. C4951012/BHV3000-407

    Pfizer Australia Pty Ltd

    migraine headaches with or without aura

    approved small molecule active

    1 trial

  24. CAIN457I2401

    Novartis Pharmaceuticals

    non-radiographic axial spondyloarthritis

    approved small molecule active

    1 trial

  25. CAPA001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atrial Fibrillation

    approved small molecule active

    1 trial

  26. CARDIOPLEGIA SOLUTIONS

    The George Institute

    Cardiovascular pathology

    approved small molecule active

    1 trial

  27. CARFLECT IV

    The George Institute

    Idiopathic ventricular arrhythmias

    approved small molecule active

    1 trial

  28. CARVECIR

    Tour Hekla

    Asymptomatic Child-Pugh A5 to B8 cirrhosis

    approved small molecule active

    1 trial

  29. CDPATH™

    Takeda

    Crohn's Disease

    approved other active

    1 trial

  30. CDRB436G2401

    Novartis Pharmaceuticals

    Children and Adolescents with Cancers Harboring V600 mutation.

    approved small molecule active

    1 trial

  31. CDRB436X2X02B

    Novartis Pharmaceuticals

    Multiple indications

    approved small molecule active

    1 trial

  32. CEFAZOLIN

    Pari Pharma GmbH

    Infection prophylaxis

    approved small molecule active

    1 trial

  33. CEFOSPROST

    The George Institute

    Acute bacterial prostatitis

    approved small molecule active

    1 trial

  34. CELC200A2406

    Novartis Pharmaceuticals

    Parkinson's Disease

    approved small molecule completed

    1 trial

  35. CELLULOSE for Angina

    Disc Medicine

    Angina

    approved small molecule active

    1 trial

  36. CELLULOSE for Mimic an acute stress response in humans.

    Disc Medicine

    Mimic an acute stress response in humans.

    approved small molecule active

    1 trial

  37. CERITINIB

    Novartis Pharmaceuticals

    non small cell lung cancer

    approved small molecule active

    1 trial

  38. CFNB group

    The First People's Hospital of Lianyungang

    Postoperative Pain

    approved other active

    1 trial

  39. CG Future Annuloplasty Ring/Band

    Rhythm Pharmaceuticals Netherlands B.V.

    Mitral Valve Insufficiency

    approved other completed

    1 trial

  40. CINC424A2X01B

    Novartis Pharmaceuticals

    This study is designed to accept patients with varied disease origins, depending on the parent protocol

    approved small molecule active

    1 trial

  41. CITISILONG

    The George Institute

    Active smokers

    approved small molecule active

    1 trial

  42. CKJX839A12402

    Novartis Pharmaceuticals

    Hypercholesterolemia

    approved small molecule active

    1 trial

  43. CKJX839A1DE02

    Novartis Pharmaceuticals

    Hypercholesterolemia

    approved small molecule active

    1 trial

  44. CLEAN+

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  45. CLEE011A2412B

    Novartis Pharmaceuticals

    HR+, HER2- advanced or metastatic breast cancer

    approved small molecule active

    1 trial

  46. CLI-05993AB1-08

    Chiesi Farmaceutici S.p.A

    Asthma

    approved small molecule active

    1 trial

  47. CLIN-52120-452

    Ipsen

    Upper limb spasticity (ULS) of any aetiology (in US and France) or post- stroke ULS (in Canada)

    approved small molecule active

    1 trial

  48. CLNP023A2002B

    Novartis Pharmaceuticals

    IgA Nephropathy

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.